Discodermolide compounds and methods of use
US6127406A · kind A · utility
9Cited by
8References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 5, 1999 |
| Grant date | Oct 3, 2000 |
| Priority date | — |
| Expiry date | Oct 5, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/366
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel analogs of compounds from the marine sponge Discodermia dissoluta have been prepared. These compounds have been shown to have activity against mammalian cancer cells, and can be used in treating human patients which host cancer cells, including leukemia, melanoma, breast, colon, CNS, renal, ovarian, prostate, and lung tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.